Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-052708

Options or other derivatives

  • Director acquired 75,893 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-10-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +15,000 15,000 D
2019-10-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +60,893 $0.99 $59,998 60,893 D
Loading xslF345X03/doc4.xml…